Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05552547

Home BP Monitoring

Home BP Monitoring for Diagnosis of Hypertension in African American Adolescents

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
750 (estimated)
Sponsor
University Hospitals Cleveland Medical Center · Academic / Other
Sex
All
Age
13 Years – 18 Years
Healthy volunteers
Accepted

Summary

Most cases of high blood pressure in teens are missed for a number of reasons. One reason is that the most common way to make a diagnosis is to make three or more blood pressure measurements in a doctor's office on separate days. This can be inconvenient. Also, measuring blood pressure in the office might be inaccurate, since children (including teens) might have high values in the office but normal values at home. For these reasons, investigators wish to study a different way to identify teens with high blood pressure. Home BP measurements have been used in Europe to make a diagnosis, but not yet in the United States, and never in a higher risk population of teens. African American teens are at higher risk for high blood pressure than other teens. Investigators will compare the values received from the home BP machines to another method (24 hour ambulatory BP monitoring or ABPM) which is the best standard for diagnosis. Investigators also want to learn more about participants experience and their child's experience with both methods. A small sample of participating teens and parents will be invited to participate in short telephone interviews. This study plans to enroll a total of 750 teens at UH. Recruitment will not take place from other organizations.

Conditions

Interventions

TypeNameDescription
DEVICEHome Blood Pressure MachineParticipants will be asked to measure blood pressure twice daily for three days in a row at home.
DEVICE24-Hour Blood Pressure MachineParticipants will be asked to wear the machine for 24 hours.

Timeline

Start date
2023-10-01
Primary completion
2026-09-30
Completion
2026-09-30
First posted
2022-09-23
Last updated
2025-12-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05552547. Inclusion in this directory is not an endorsement.